Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Harvard Business School
McKinsey
Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VIIBRYD

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Viibryd

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01473381 Safety and Efficacy of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2011-12-01 The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.
NCT01473394 Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2011-12-01 The purpose of this study was to further characterize the efficacy, safety, and tolerability of a single fixed dose level of vilazodone compared to placebo in patients with major depressive disorder.
NCT01573598 Safety and Efficacy of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2012-04-01 Safety and Efficacy of Vilazodone in Major Depressive Disorder
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Viibryd

Condition Name

Condition Name for Viibryd
Intervention Trials
Major Depressive Disorder 9
Hot Flushes 1
Sexual Dysfunction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Viibryd
Intervention Trials
Depressive Disorder, Major 10
Depressive Disorder 10
Depression 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Viibryd

Trials by Country

Trials by Country for Viibryd
Location Trials
United States 134
Ukraine 5
Serbia 4
Canada 4
Finland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Viibryd
Location Trials
Texas 7
Florida 7
California 7
New York 7
Virginia 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Viibryd

Clinical Trial Phase

Clinical Trial Phase for Viibryd
Clinical Trial Phase Trials
Phase 4 7
Phase 3 4
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Viibryd
Clinical Trial Phase Trials
Completed 10
Recruiting 3
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Viibryd

Sponsor Name

Sponsor Name for Viibryd
Sponsor Trials
Forest Laboratories 13
The Medical Research Network 1
University of Pennsylvania 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Viibryd
Sponsor Trials
Industry 13
Other 9
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Moodys
Dow
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.